Bandaríkin - enska - NLM (National Library of Medicine)

schering plough healthcare products - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - chlorpheniramine maleate 12 mg

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - levamisole hydrochloride; albendazole oxide - oral solution/suspension - levamisole hydrochloride anthelmintic active 82.5 g/l; albendazole oxide carbamate-benzimidazole active 36.0 g/l - parasiticides

Nýja-Sjáland - enska - Ministry for Primary Industries

schering-plough animal health limited - dexamethasone - dexamethasone 2 g/litre - endocrine agent (hormone)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 100 mg - capsule, hard - excipient ingredients: tartaric acid; sodium lauryl sulfate; iron oxide red; lactose; colloidal anhydrous silica; stearic acid; gelatin; sodium starch glycollate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 20 mg - capsule, hard - excipient ingredients: tartaric acid; colloidal anhydrous silica; iron oxide yellow; gelatin; lactose; sodium lauryl sulfate; stearic acid; titanium dioxide; sodium starch glycollate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 5 mg - capsule, hard - excipient ingredients: indigo carmine; sodium lauryl sulfate; tartaric acid; iron oxide yellow; lactose; colloidal anhydrous silica; sodium starch glycollate; gelatin; stearic acid; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Bandaríkin - enska - NLM (National Library of Medicine)

personal care products, inc. - tolnaftate (unii: 06kb629tkv) (tolnaftate - unii:06kb629tkv) - tolnaftate 1 g in 100 g - antifungal - cures most athlete's foot (tinea pedis) and ringworm (tinea corporis) - if used daily, can prevent recurrence of athlete's foot - relieves symptoms of athlete's foot, including itching, burning and cracking - irritation occurs - there is no improvement after 4 weks

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - dexchlorpheniramine maleate 6mg (overage of 5.5% used during manufacture) - modified release tablet - 6 mg - active: dexchlorpheniramine maleate 6mg (overage of 5.5% used during manufacture) excipient: acacia calcium phosphate calcium sulfate dihydrate carnauba wax colophony gelatin soap: schering-plough company monograph lactose monohydrate magnesium stearate maize starch methyl hydroxybenzoate oleic acid purified talc sucrose white beeswax zein

Ísrael - enska - Ministry of Health

intervet ( israel) ltd - florfenicol - solution for injection - florfenicol 300 mg/ml - treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, paasteurella multocida and haemophilus somnus.treatment of ovine respiratory tract infections due to mannheimia haemolytica and pasteurella multocida susceptible to florfenicol.